Advertisement
News
Advertisement

Frost & Sullivan Recognizes Cohera Medical, Inc.® for Developing TissuGlu®, Its Pioneering Surgical Adhesive That Is Strong, Easy-To-Use, Biocompatible and Resorbable

Tue, 01/25/2011 - 4:31am
Bio-Medicine.Org

MOUNTAIN VIEW, Calif., Jan. 25, 2011 /PRNewswire/ -- Based on its recent analysis of the surgical adhesives market, Frost & Sullivan recognizes Cohera Medical, Inc. with the 2010 Frost & Sullivan Award for New Product Innovation of the Year Award for TissuGlu. With surgeons looking for better surgical adhesive options than the currently available superglue-type products and fibrin sealants, Cohera Medical's revolutionary line of internal surgical adhesives, with TissuGlu as the lead product, could not have been timelier.

While superglue-type products are known for their adhesive strength, in general they do not degrade and so they cannot be used inside the body. Fibrin sealants, on the other hand, can be used for internal applications, but create a weak bond and are expensive. They also need to be prepared prior to use and can be difficult to use during surgery. As a logical derivative, surgeons want a product that is strong, easy-to-use and affordable, while being biocompatible and resorbable. TissuGlu, a urethane adhesive suited for plastic surgery procedures, is both biocompatible and resorbable, making it ideal for internal applications. It is also strong, user-friendly, and does not contain human/animal product derivatives.

"Although the medical adhesives industry is regarded as an exciting, emerging market in the world today, there are only a few manufacturers that actually research technologies that are capable of clinical feasibility," says Frost & Sullivan Senior Research Analyst Christina Priya Dhanuja. "For the development of TissuGlu, Cohera Medical has keenly worked on the modification of the urethane chemistry to suit the needs of a surgical adhesive requirement."

By efficiently adhering flaps of tissue, TissuGlu is particularly useful in preventing the formation of seroma in abdominoplasty. One of the five most common plastic surgery procedures performed in the United States, abdominoplasty has a reported post-opera

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading